In Vitro Antifungal Activity of Micafungin and Caspofungin Against Dermatophytes Isolated from China

Mycopathologia

Volumn 175, Issue 1-2, 2013, Pages 141-145

  Bao, Ying qiu ^a,b   Wan, Zhe ^a   Li, Ruo yu ^a  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

^b BEIJING HOSPITAL   (China)

Author keywords

Antifungal susceptibility testing; Caspofungin; Dermatophyte; In vitro; Micafungin

Indexed keywords

ARTHRODERMA BENHAMIAE; ARTHRODERMATACEAE; CANIS FAMILIARIS; EPIDERMOPHYTON FLOCCOSUM; MICROSPORUM CANIS; TRICHOPHYTON RUBRUM; TRICHOPHYTON TONSURANS; TRICHOPHYTON VERRUCOSUM; TRICHOPHYTON VIOLACEUM;

EID: 84872788572     PISSN: 0301486X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11046-012-9571-6     Document Type: Article

References (10)

1. Douglas CM. Fungal beta(1, 3)-d-glucansynthesis. Med Mycol. 2001; 39(suppl 1): 55-66.
2. Maesaki S, Hossain MA, Miyazaki Y, Tomono K, Tashiro T, Kohno S. Efficacy of FK463, a (1, 3)-beta-d-glucan synthase inhibitor, in disseminated azole-resistant Candida albicans infection in mice. Antimicrob Agents Chemother. 2000; 44: 1728-30.
3. Sevtap A, Yurdakul P, Hascelik G. Comparison of two methods and three end points in determination of in vitro activity of micafungin against Aspergillus spp. Antimicrob Agents Chemother. 2003; 47: 2640-3.
4. Theuretzbacher U. Pharmacokinetics/pharmacodynamics of echinocandins. Eur J Clin Microbiol Infect Dis. 2004; 23: 805-12.
5. Clinical and Laboratory Standards Institute. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi; approved standard-M38-A2. Wayne, PA, USA: CLSI; 2008.
6. Berg JC, Hamacher KL, Roberts GD. Pseudomycetoma caused by Microsporum canis in an immunosuppressed patient: a case report and review of the literature. J Cutan Pathol. 2007; 34: 431-4.
7. Nir-Paz R, Elinav H, Pierard GE, Walker D, Maly A, Shapiro M, Barton RC, Polacheck I. Deep infection by Trichophyton rubrum in an immunocompromised patient. J Clin Microbiol. 2003; 41: 5298-301.
8. Imhof A, Balajee SA, Marr KA. New methods to assess susceptibilities of Aspergillus isolates to caspofungin. J Clin Microbiol. 2003; 41: 5683-8.
9. Cetinkaya Z, Kiraz N, Karaca S, Kulac M, Ciftci IH, Aktepe OC, Altindis M, Kiyildi N, Piyade M. Antifungal susceptibilities of dermatophytic agents isolated from clinical specimens. Eur J Dermatol. 2005; 15: 258-61.
10. Nakai T, Uno J, Otomo K, Ikeda F, Tawara S, Goto T, Nishimura K, Miyaji M. In vitro activity of FK463, a novel lipopeptide antifungal agent, against a variety of clinically important molds. Chemotherapy. 2002; 48: 78-81.